Brandywine Oak Private Wealth LLC Abb Vie Inc. Transaction History

Brandywine Oak Private Wealth LLC

$1.02 Billion
Q4 2024

A detailed history of Brandywine Oak Private Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Brandywine Oak Private Wealth LLC holds 12,041 shares of ABBV stock, worth $2.3 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

12,041

Previous 13,506 10.85%

Holding current value

$2.3 Million

Previous $2.67 Million 19.8%

% of portfolio

0.21%

Previous 0.26%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$164.99 - $203.87 $241,710 - $298,669	-1,465 Reduced 10.85%	12,041 $2.14 Million
Q3 2024 Nov 07, 2024	BUY	$163.84 - $199.33 $9,338 - $11,361	57 Added 0.42%	13,506 $2.67 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $108,507 - $126,712	-701 Reduced 4.95%	13,449 $2.31 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $58,334 - $66,466	365 Added 2.65%	14,150 $2.58 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $45,270 - $50,985	-329 Reduced 2.33%	13,785 $2.14 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1,603 - $1,855	-12 Reduced 0.08%	14,114 $2.1 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $16,431 - $20,447	124 Added 0.89%	14,126 $1.9 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $3,036 - $3,497	-21 Reduced 0.15%	14,002 $2.23 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $179,664 - $215,465	-1,299 Reduced 8.48%	14,023 $2.27 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $21,607 - $24,782	-161 Reduced 1.04%	15,322 $2.06 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $64,681 - $82,231	-470 Reduced 2.95%	15,483 $2.37 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $4,223 - $5,240	32 Added 0.2%	15,953 $2.59 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $48,450 - $61,304	451 Added 2.92%	15,921 $2.16 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $88,524 - $100,488	832 Added 5.68%	15,470 $1.67 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $843,678 - $939,906	8,019 Added 121.15%	14,638 $1.65 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $1,432 - $1,576	-14 Reduced 0.21%	6,619 $716,000
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $14,085 - $19,017	175 Added 2.71%	6,633 $710,000
Q3 2020 Oct 16, 2020	BUY	$85.91 - $100.83 $7,388 - $8,671	86 Added 1.35%	6,458 $565,000
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $64,272 - $86,005	876 Added 15.94%	6,372 $625,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $2,644 - $4,009	-41 Reduced 0.74%	5,496 $418,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $504 - $631	7 Added 0.13%	5,537 $490,000
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $115,064 - $138,340	1,827 Added 49.34%	5,530 $418,000
Q2 2019 Jul 22, 2019	BUY	$65.7 - $83.98 $2,430 - $3,107	37 Added 1.01%	3,703 $269,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $115,787 - $136,275	-1,501 Reduced 29.05%	3,666 $295,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $402,250 - $496,083	5,167 New	5,167 $476,000

Others Institutions Holding ABBV

# of Institutions

3,943

Shares Held

1.26B

Call Options Held

16.8M

Put Options Held

12.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Oak Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Oak Private Wealth LLC with notifications on news.

Account

Brandywine Oak Private Wealth LLC Abb Vie Inc. Transaction History